- Report
- November 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- December 2023
- 180 Pages
Global
From €4635EUR$4,795USD£3,984GBP
- Report
- June 2021
- 213 Pages
Global
From €2658EUR$2,750USD£2,285GBP
€5317EUR$5,500USD£4,570GBP
- Report
- July 2021
- 50 Pages
China
From €2513EUR$2,600USD£2,160GBP
- Report
- August 2022
- 82 Pages
Global
From €3379EUR$3,495USD£2,904GBP
- Report
- May 2022
- 243 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Drug Pipelines
- June 2021
- 62 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Drug Pipelines
- March 2021
Global
From €1933EUR$2,000USD£1,662GBP
The Fungal Infection Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases caused by bacteria, viruses, fungi, and parasites. Fungal Infection Drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common fungal infections include athlete's foot, ringworm, and yeast infections.
Fungal Infection Drugs are available in a variety of forms, including tablets, capsules, creams, and ointments. These drugs are typically prescribed by a doctor and can be purchased over-the-counter or online.
Some companies in the Fungal Infection Drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Bayer. Show Less Read more
